Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arava Bio Tech
Israel
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Arava Bio Tech develops and markets innovative pet skin and coat bio-care solutions, based on natural ingredients and Dead Sea minerals, aimed at protecting and promoting pet dermatological health through cleansing, anti-microbial, anti-parasitic, and conditioning products. There is no evidence of human clinical trials, advanced investigational drugs, or regulatory filings typical of pharma/biotech firms targeting human disease.
- Therapeutic areas
- Infectious DiseasesDermatology
- Modalities
- Other (veterinary skin/coat care; likely topical, natural extracts, Dead Sea minerals)Natural extractsTopical dermatology formulations
- Industry
- Veterinary
Beyond the preview
Go deeper on Arava Bio Tech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arava Bio Tech.